Up-to date view on -blocker in treatment of arterial hypertension with heart failure

Up-to date view on -blocker in treatment of arterial hypertension with heart failure

Bibliographic Details
Main Authors:	Galina Nikolaevna Gorokhovskaya, Mariya Mikhaylovna Petina, Evgeniy Gennadievich Nikolau, Anatoliy Ivanovich Martynov, G N Gorohovskaja, M M Petina, E G Nikolau, A I Martynov
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2009-03-01
Series:	Системные гипертензии
Subjects:	arterial hypertension heart failure b-blockers
Online Access:	https://syst-hypertension.ru/2075-082X/article/view/33044

Similar Items

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
by: M. M. Petina, et al.
Published: (2011-04-01)

An old patient with iron deficient anemia in therapeutic practice
by: G N Gorokhovskaya, et al.
Published: (2008-12-01)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
by: Irina Evgen'evna Chazova, et al.
Published: (2009-03-01)

Anemiya pri zlokachestvennykhnovoobrazovaniyakh: printsipy terapii
by: G N Gorokhovskaya, et al.
Published: (2011-06-01)

Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta
by: G N Gorokhovskaya, et al.
Published: (2005-06-01)

The modern view of general practitioner on the problem of iron deficiency anemia in patients with cardiovascular pathology
by: G. N. Gorohovskaya, et al.
Published: (2020-10-01)

Could beta blocker use in elderly hypertensive patients reduce risk of skin cancers?
by: Habibullah Aktas, et al.
Published: (2019-12-01)

Effect of different beta blockers on penile vascular velocities in hypertensive males
by: Samer Malak Botros, et al.
Published: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

The role of b-blockers in treatment of hypertension, according to Russian and European experts
by: O D Ostroumova, et al.
Published: (2016-03-01)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
by: Maddalena Ardissino, et al.
Published: (2022-09-01)

Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
by: Junxiong Lin, et al.
Published: (2023-05-01)

The new widely discussed clinically significant aspects influence of β-blockers
by: G P Arutyunov
Published: (2013-03-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

The association of exaggerated hypertensive response to exercise and beta-blockers use in hypertensives
by: Kadir Uğur Mert, et al.
Published: (2020-11-01)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
by: José Luño, et al.
Published: (2017-07-01)

PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

The Influence of Sociological Variables on Users’ Feelings about Programmatic Advertising and the Use of Ad-Blockers
by: Enrique Rus-Arias, et al.
Published: (2021-01-01)

Effect of calcium channel blockers on gingival tissues in hypertensive patients in Lagos, Nigeria: A pilot study
by: Kehinde Adesola Umeizudike, et al.
Published: (2017-01-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
by: Kazufumi Nakamura, et al.
Published: (2011-08-01)

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
by: A. O. Konradi, et al.
Published: (2018-12-01)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
by: Ahmet Anık
Published: (2022-12-01)

Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas
by: Klara Maresova, et al.
Published: (2021-06-01)

Beta-Blockers and Cancer: Where Are We?
by: Rita Peixoto, et al.
Published: (2020-05-01)

Efficacy of beta-blockers in the treatment of sepsis
by: Peng Jin, et al.
Published: (2021-01-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
by: Tao Liu, et al.
Published: (2023-01-01)

Poor tolerance of beta-blockers by elderly patients with heart failure
by: Satoshi Yanagisawa, et al.
Published: (2010-11-01)

Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
by: Mochamad Yusuf Alsagaff, et al.
Published: (2021-11-01)

Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis
by: Seok-Hui Kang, et al.
Published: (2023-10-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Role of α1‐blockers in the current management of hypertension
by: Hua Li, et al.
Published: (2022-09-01)

Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure
by: Girouard C, et al.
Published: (2016-09-01)

Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension
by: Eva Kociánová, et al.
Published: (2017-09-01)

Beta-blockers in chronic heart failure in elderly patient
by: Alberto De Bernardi
Published: (2009-06-01)

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
by: Andrew S. Perry, et al.
Published: (2023-06-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine
by: Keisuke Okamura, et al.
Published: (2018-02-01)